EP1765452A4 - SUPPLY SYSTEM - Google Patents

SUPPLY SYSTEM

Info

Publication number
EP1765452A4
EP1765452A4 EP05769226A EP05769226A EP1765452A4 EP 1765452 A4 EP1765452 A4 EP 1765452A4 EP 05769226 A EP05769226 A EP 05769226A EP 05769226 A EP05769226 A EP 05769226A EP 1765452 A4 EP1765452 A4 EP 1765452A4
Authority
EP
European Patent Office
Prior art keywords
delivery system
vaginal cavity
internal phase
high internal
emulsion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05769226A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1765452A1 (en
Inventor
Robert C Cuca
Thomas C Riley
R Saul Levinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amag Pharma USA Inc
Original Assignee
Drugtech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drugtech Corp filed Critical Drugtech Corp
Publication of EP1765452A1 publication Critical patent/EP1765452A1/en
Publication of EP1765452A4 publication Critical patent/EP1765452A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/42—Gynaecological or obstetrical instruments or methods
    • A61B2017/4216—Operations on uterus, e.g. endometrium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Dispersion Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
EP05769226A 2004-07-08 2005-07-08 SUPPLY SYSTEM Withdrawn EP1765452A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58627304P 2004-07-08 2004-07-08
PCT/US2004/022058 WO2006016869A1 (en) 2004-07-08 2004-07-08 Delivery system
PCT/US2005/024200 WO2006014572A1 (en) 2004-07-08 2005-07-08 Delivery system

Publications (2)

Publication Number Publication Date
EP1765452A1 EP1765452A1 (en) 2007-03-28
EP1765452A4 true EP1765452A4 (en) 2012-11-28

Family

ID=35787422

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05769226A Withdrawn EP1765452A4 (en) 2004-07-08 2005-07-08 SUPPLY SYSTEM

Country Status (13)

Country Link
EP (1) EP1765452A4 (cs)
CN (2) CN1771023A (cs)
AU (2) AU2004100776A4 (cs)
BR (1) BRPI0513066A (cs)
CA (1) CA2572919A1 (cs)
CZ (1) CZ15068U1 (cs)
ES (1) ES1060042Y (cs)
FR (1) FR2872702B3 (cs)
MX (2) MXPA04007681A (cs)
NL (1) NL1026978C1 (cs)
NZ (1) NZ552406A (cs)
RU (1) RU2379027C2 (cs)
WO (2) WO2006016869A1 (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2008651A1 (en) * 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
EP2100632A1 (en) 2008-03-11 2009-09-16 Pantarhei Devices B.V. Applicator device for body cavity
US8308678B2 (en) 2008-09-23 2012-11-13 Mcneil-Ppc, Inc. Pre-filled applicator device
EP2359750A1 (en) 2010-02-15 2011-08-24 Delphi Bioscience B.V. Screening device with valve
FR2968004B1 (fr) 2010-11-29 2013-06-28 Sojasun Technologies Films naturels biodegradables a base de co-produits issus de processus industriels de traitement de graines.
RU2538703C2 (ru) * 2013-03-12 2015-01-10 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения вагинального кандидоза и способ ее получения
CN108371746B (zh) * 2015-09-18 2021-01-05 宋殿芳 一种妇科的外用药防脱落的施药装置
WO2019241210A1 (en) * 2018-06-11 2019-12-19 The Procter & Gamble Company Methods and applicators for treating vaginal conditions
CN112716796B (zh) * 2018-12-11 2022-07-08 管云 助力配药器

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266329A (en) * 1985-10-31 1993-11-30 Kv Pharmaceutical Company Vaginal delivery system
US5536743A (en) * 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3045913A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung
US4636202A (en) * 1984-07-27 1987-01-13 Syntex (U.S.A.) Inc. Medicament applicator with plunger assembly and automatically-openable closure therefor
CA1337279C (en) * 1989-06-06 1995-10-10 Robert J. Borgman Intravaginal treatment of vaginal infections with buffered metronidazole compositions
ES2133090B1 (es) * 1997-02-21 2000-04-01 Uriach & Cia Sa J Nuevo aplicador para la administracion de medicaciones semisolidas.
US6403576B1 (en) * 1998-08-24 2002-06-11 The United States Of America As Represented By The Secretary Of The Navy Antifungal and antiparasitic compounds
US20040047910A1 (en) * 2000-07-07 2004-03-11 Christian Beckett Suppository and composition comprising at least one polyethylene glycol
RU2207870C2 (ru) * 2000-11-10 2003-07-10 Панацея Биотек Лимитед Фармацевтическая композиция, включающая циклоспорин в качестве активного ингредиента

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266329A (en) * 1985-10-31 1993-11-30 Kv Pharmaceutical Company Vaginal delivery system
US5536743A (en) * 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO2006014572A1 *
WEINSTEIN L; HENZEL M R; TSINA I W: "Vaginal retention of 2% butoconazole nitrate cream: comparison of a standard and a sustained-release preparation", CLINICAL THERAPEUTICS, vol. 16, no. 6, 1994, pages 930 - 934, XP008157356 *

Also Published As

Publication number Publication date
FR2872702B3 (fr) 2006-06-02
CA2572919A1 (en) 2006-02-09
CN102188375A (zh) 2011-09-21
ES1060042U (es) 2005-07-16
ES1060042Y (es) 2005-11-01
NL1026978C1 (nl) 2006-01-10
EP1765452A1 (en) 2007-03-28
BRPI0513066A (pt) 2008-04-22
MXPA04007681A (es) 2006-01-12
CN1771023A (zh) 2006-05-10
WO2006014572A1 (en) 2006-02-09
AU2004100776A4 (en) 2004-11-18
NZ552406A (en) 2010-07-30
RU2379027C2 (ru) 2010-01-20
AU2005269844A1 (en) 2006-02-09
RU2007104782A (ru) 2008-08-20
MX2007000109A (es) 2007-03-26
WO2006016869A1 (en) 2006-02-16
CZ15068U1 (cs) 2005-01-31
FR2872702A3 (fr) 2006-01-13

Similar Documents

Publication Publication Date Title
MXPA03010402A (es) Derivados de 4-amino-5-fenil-7-ciclobutil-pirrolo (2,3-d) pirimidina.
PH12021551792A1 (en) Bi-ligand drug conjugate and use thereof
IL252715A0 (en) Combinations and forms of administration of therapeutic agents and combined treatment
BR0316157A (pt) Derivados de 4-amino-5-fenil-7-ciclohexil-pirrolo[2,3-d]pirimidina
BRPI0513200A (pt) uso de um anticorpo anti-igf-1r na preparação de um medicamento para tratamento combinado para malignidades não-hematológicas
BR0306501A (pt) Método para uso e produção de um tampão com medicamento
PH12018502124B1 (en) Liquid formulations of (s)-n-(5-((r)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide
WO2004064734A3 (en) Combination therapies for the treatment of cancer
WO2007098479A3 (en) Localized insulin delivery for bone healing
BR112019006228A2 (pt) tratamento de câncer de próstata
MX2009004017A (es) Usos de los compuestos carboxi-amido triazol y sus sales.
EP1765452A4 (en) SUPPLY SYSTEM
WO2006029036A3 (en) Combination therapy with glatiramer acetate and n-acetylcysteine for the treatment of multiple sclerosis
ZA202101688B (en) Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain
MY142098A (en) Delivery system
PA8624501A1 (es) Piperazinas derivadas de úrea para el tratamiento de la endometrosis
JOP20180088B1 (ar) صيغ سائلة من (s)-n-(5-((r)-2-(2، 5-داي فلورو فينيل)-بيروليدين-1-يل)-بيرازولو[1، 5-a] بيريميدين-3-يل)-3-هيدروكسي بيروليدين-1-كربوكساميد
TH84091A (th) ระบบการส่งมอบ
YU17703A (sh) Nova farmaceutska kompozicija za primenu na koži
TH1801006190A (th) สารประกอบสำหรับการผลิตสูตรผสมที่เป็นของเหลวสำหรับการรักษามะเร็งในเด็ก
UA48739U (ru) СПОСОБ ЛЕЧЕНИЯ ОСТРЫХ РЕСПИРАТОРНЫХ ЗАБОЛЕВАНИЙ У ТЕЛЯТ|телят|
HN1999000087A (es) Aparato dispensador de polvo seco y metodos de uso del mismo
AR073363A1 (es) Composicion farmaceutica para el uso en el tratamiento de infecciones de transmision sexual y proceso de elaboracion

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070108

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1100073

Country of ref document: HK

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20121030

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/10 20060101ALI20121024BHEP

Ipc: A61K 31/4164 20060101ALI20121024BHEP

Ipc: A61M 31/00 20060101AFI20121024BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130201

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1100073

Country of ref document: HK